An Act To Support Healthy Weight By Providing Mainecare Coverage For Certain Weight Loss Medications

This bill requires MaineCare (Maine's Medicaid program) to cover FDA-approved weight loss medications called glucagon-like peptide-1 receptor agonists for obesity treatment. It directly affects MaineCare beneficiaries seeking these medications, expanding coverage previously unavailable under the program. The key mechanisms include restricting coverage to prescriptions from primary care providers or bariatric specialists and requiring prior authorization before coverage is granted. This policy change formally adds specific weight loss medications to MaineCare's covered services list.